Skip Navigation

Journal of Biochemistry 2005 138(2):127-134; doi:10.1093/jb/mvi110
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Oyama, H.
Right arrow Articles by Oda, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oyama, H.
Right arrow Articles by Oda, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 The Japanese Biochemical Society

Regular Paper

Catalytic Residues and Substrate Specificity of Recombinant Human Tripeptidyl Peptidase I (CLN2)

Hiroshi Oyama1, Tomoko Fujisawa1, Takao Suzuki2, Ben M. Dunn3, Alexander Wlodawer4 and Kohei Oda1,*

1 Department of Applied Biology, Faculty of Textile Science, Kyoto Institute of Technology, Matsugasaki, Sakyo-ku, Kyoto 606-8585; 2 Chuo-Sanken Laboratory, Katakura Industries Co., Ltd. Sayama, Saitama 350-1352; 3 Department of Biochemistry and Molecular Biology, University of Florida College of Medicine, Gainesville, Florida 32610-0245, USA; and 4 Protein Structure Section, Macromolecular Crystallography Laboratory, National Cancer Institute, Frederick, Maryland 21702-1201, USA

* To whom correspondence should be addressed. Tel: +81-75-724-7763, Fax: +81-75-724-7760, E-mail: bika{at}ipc.kit.ac.jp

Tripeptidyl peptidase I (TTP-I), also known as CLN2, a member of the family of serine-carboxyl proteinases (S53), plays a crucial role in lysosomal protein degradation and a deficiency in this enzyme leads to fatal neurodegenerative disease. Recombinant human TPP-I and its mutants were analyzed in order to clarify the biochemical role of TPP-I and its mechanism of activity. Ser280, Glu77, and Asp81 were identified as the catalytic residues based on mutational analyses, inhibition studies, and sequence similarities with other family members. TPP-I hydrolyzed most effectively the peptide Ala-Arg-Phe*Nph-Arg-Leu (*, cleavage site) (k cat/K m = 2.94 µM–1·s–1). The k cat/K m value for this substrate was 40 times higher than that for Ala-Ala-Phe-MCA. Coupled with other data, these results strongly suggest that the substrate-binding cleft of TPP-I is composed of only six subsites (S3-S3'). TPP-I prefers bulky and hydrophobic amino acid residues at the P1 position and Ala, Arg, or Asp at the P2 position. Hydrophilic interactions at the S2 subsite are necessary for TPP-I, and this feature is unique among serine-carboxyl proteinases. TPP-I might have evolved from an ancestral gene in order to cleave, in cooperation with cathepsins, useless proteins in the lysosomal compartment.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Histochem. Cytochem.Home page
R. Steinfeld, J. C. Fuhrmann, and J. Gartner
Detection of Tripeptidyl Peptidase I Activity in Living Cells by Fluorogenic Substrates
J. Histochem. Cytochem., September 1, 2006; 54(9): 991 - 996.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Tian, I. Sohar, J. W. Taylor, and P. Lobel
Determination of the Substrate Specificity of Tripeptidyl-peptidase I Using Combinatorial Peptide Libraries and Development of Improved Fluorogenic Substrates
J. Biol. Chem., March 10, 2006; 281(10): 6559 - 6572.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.